Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Любов Володимирівна Шкала, Любовь Владимировна Шкала, Олена Валеріївна Соніна, Елена Валерьевна СонинаfiledCriticalЛюбов Володимирівна Шкала
Priority to UAU201209902UpriorityCriticalpatent/UA75872U/en
Publication of UA75872UpublicationCriticalpatent/UA75872U/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
A method for the rehabilitation of the patients with ischemic heart disease in combination with diabetes mellitus type 2 provides for daily use of angiotensin-converting enzyme inhibitor, selective beta-adrenoblocker, desaggregant, statin, sugar-decreasing drug Diabeton MR. 4.2 % solution of Tivortin is used for 10 days followed by Tivortin aspartate for 6 weeks. The total duration of the treatment is 2 months.
UAU201209902U2012-08-162012-08-16Method for rehabilitation of patients with ischemic heart disease in combination with diabetes mellitus type 2
UA75872U
(en)